Patent · US Active

Solvent resistant diafiltration of peptides, PNA or oligonucleotides

US8664357B2 · kind B2 · utility

13Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2009
Grant dateMar 4, 2014
Priority date
Expiry dateSep 4, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K1/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

According to the present invention, there is provided a process for the preparation of a first compound selected from peptides, oligonucleotides and peptide nucleic acids. The process comprises synthesizing the first compound and then separating the first compound formed in step (i) from a second compound, which is a reaction by-product of the synthesis of the first compound and/or an excess of a reagent used for the synthesis of a first compound by a process of diafiltration. The membrane used for the diafiltration process is stable in organic solvents and provides a rejection for the first compound which is greater than the rejection for the second compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.